Setting the median expression of HERC3 as the cutoff values, CRC patients were classified into 2 groups, and the patients who owned relatively higher HERC3 protein expression presented relatively low protein levels of RPL23A and vice versa (Figure 3G). The gene discussed is HERC3; the disease is colorectal carcinoma.